MedTrace Logo

Safety & Efficacy of Extended Longevity Protocol

NCT05296993 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-05-11

No results posted yet for this study

Summary

The purpose of this study is to quantifiably determine if the Extended Longevity Protocol has a significant clinical effect on epigenetic age.

Conditions

  • Aging

Interventions

DIETARY_SUPPLEMENT

Extracts found in the Extended Longevity supplements

Ingredients found in these serums are all naturally occurring, and extracted from a variety of plant species.

Sponsors & Collaborators

  • TruDiagnostic

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05296993 on ClinicalTrials.gov